Make your products visible globally with Elite Membership.
I agree to the terms and conditions
Existing User?
Sign In with Email
Remember Me Forgot Password?
New User?
Enter your registered Email ID to get reset password.
Elite Member
Individual Register
BASEL, SWITZERLAND: Lonza recently said that it has signed a new development and manufacturing agreement with Athera Biotechnologies AB, part of the Karolinska Development AB portfolio. Lonza will initiate cell line and process development for Athera’s monoclonal antibody PC-mAb. Athera’s PC-mAb is intended for the treatment of patients with Acute Coronary Syndrome who are at an increased risk of secondary cardiovascular events and death.
This agreement secures a development and cGMP manufacturing plan for Athera. Lonza will initiate cell line and process development, using Lonza’s GS Gene Expression SystemTM.
“Lonza is pleased to continue our support of emerging biotech companies with this commitment to Athera’s promising pipeline. The PC-mAb project from Athera fits well with Lonza’s core competencies and technical experience,” said Stephan Kutzer, Head-Custom Manufacturing Division, Lonza.
© WOC News
Login
THE WOODLANDS, US: Chevron Phillips Chemical Company LP (Chevron Phillips Chemical) said that it is advancing a feasibility study to construct ...
TOKYO, JAPAN: Shin-Etsu Group’s reported that there has been little change in their situation since March 22nd. All of operations at bot ...
BASEL, SWITZERLAND: Lonza will invest £16 million to further develop the flexibility and capability of its Slough, UK biopharmaceutical ...
By co-operating to generate synergies in technological development, marketing and R&D, both companies seek to expand their businesses in t ...
PERSTORP, SWEDEN: Perstorp is extending capacity for 2-EHA in Europe and Asia by establishing production at the group’s manufacturing un ...
LONDON, UK: British private equity firm 3i Group has kicked off the sale of Azelis, a Belgium headquartered chemicals distributor with 1 billi ...
Stay updated with the latest chemical industry trends and innovations.
Verification Code has been sent to
Please enter the Verification Code below to verify your Email Address.If you cannot see the email from "noreply@worldofchemicals.com" in your inbox,make sure to check your SPAM Folder